GlassScriptPhysician profile
Lily Liang
NPI 1609355791
$10,617.14
in general payments reported to CMS, 2019-2025
19 companies · $576 in 2025
The $576 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,129 · 2022: $7,709 · 2023: $509 · 2024: $693 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,778.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,723.02 | 2022 | |
| Gotham Surgical Solutions & Devices, INC. | $1,494.03 | 2021-2022 | |
| Stryker Corporation | $1,236.02 | 2021-2024 | Variax, Vitoss, Axsos |
| Orthofix Medical, INC. | $277.17 | 2025 | Physio-Stim |
| Djo, LLC | $265.05 | 2021-2024 | Cmf |
| Polynovo North America LLC | $214.03 | 2024 | Novosorb Btm |
| Bioventus LLC | $196.39 | 2021 | |
| Suvon Surgical LLC | $187.02 | 2023-2025 | |
| Boston Scientific Corporation | $173.20 | 2025 | Wavewriter Alpha Prime 16 |
| Heron Therapeutics, INC. | $136.55 | 2021 | |
| Integra Lifesciences Corporation | $131.82 | 2022 | |
| Mirati Therapeutics, INC. | $125.01 | 2023 | Krazati |
| Smith+Nephew, INC. | $116.60 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.95 | 2022 | |
| Zimvie INC. | $72.52 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $58.50 | 2023-2024 | Orthovisc, Monovisc |
| Endo USA, INC. | $48.24 | 2025 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $33.15 | 2025 | |
| Avanos Medical | $13.87 | 2025 | Trivisc Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lily Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.